- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Circulating tumor DNA for personalized lung cancer monitoring ; volume:15 ; number:1 ; day:17 ; month:8 ; year:2017 ; pages:1-3 ; date:12.2017
BMC medicine ; 15, Heft 1 (17.8.2017), 1-3, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Fiala, Clare
- Contributor
-
Diamandis, Eleftherios P.
SpringerLink (Online service)
- DOI
-
10.1186/s12916-017-0921-6
- URN
-
urn:nbn:de:1111-2017102618106
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fiala, Clare
- Diamandis, Eleftherios P.
- SpringerLink (Online service)
Other Objects (12)
Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma
Personalized treatment selection and disease monitoring using circulating tumor DNA profiling in real-world cancer patient management
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer
Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis
A Personalized Arrhythmia Monitoring Platform
Neoantigen Tracking: Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer (Adv. Sci. 9/2020)
Personalized follow-up of circulating DNA in resected stage III/IV melanoma: PERCIMEL multicentric prospective study protocol
Monitoring of measurable residual disease using circulating DNA after allogeneic hematopoietic cell transplantation
Genotyping of circulating free DNA enables monitoring of tumor dynamics in synovial sarcomas
Spatial and temporal heterogeneity of lung adenocarcinomas in tumor tissues and circulating DNA
Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer
Circulating tumor DNA in early‐stage breast cancer: personalized biomarkers for occult metastatic disease and risk of relapse?
Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma
Personalized treatment selection and disease monitoring using circulating tumor DNA profiling in real-world cancer patient management
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer
Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis
A Personalized Arrhythmia Monitoring Platform
Neoantigen Tracking: Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer (Adv. Sci. 9/2020)
Personalized follow-up of circulating DNA in resected stage III/IV melanoma: PERCIMEL multicentric prospective study protocol
Monitoring of measurable residual disease using circulating DNA after allogeneic hematopoietic cell transplantation
Genotyping of circulating free DNA enables monitoring of tumor dynamics in synovial sarcomas
Spatial and temporal heterogeneity of lung adenocarcinomas in tumor tissues and circulating DNA
Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer
Circulating tumor DNA in early‐stage breast cancer: personalized biomarkers for occult metastatic disease and risk of relapse?
Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma
Personalized treatment selection and disease monitoring using circulating tumor DNA profiling in real-world cancer patient management
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer
Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis
A Personalized Arrhythmia Monitoring Platform
Neoantigen Tracking: Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer (Adv. Sci. 9/2020)
Personalized follow-up of circulating DNA in resected stage III/IV melanoma: PERCIMEL multicentric prospective study protocol
Monitoring of measurable residual disease using circulating DNA after allogeneic hematopoietic cell transplantation
Genotyping of circulating free DNA enables monitoring of tumor dynamics in synovial sarcomas
Spatial and temporal heterogeneity of lung adenocarcinomas in tumor tissues and circulating DNA
Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer